Annemarie Stoudt Cohen

Title: Annemarie Stoudt Cohen: Innovator in Intranasal Insulin Delivery

Introduction

Annemarie Stoudt Cohen is a notable inventor based in Kirkland, WA (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the delivery of insulin. Her innovative work has the potential to improve the lives of many patients requiring insulin therapy.

Latest Patents

Annemarie holds a patent for "Compositions for intranasal delivery of human insulin and uses thereof." This patent describes a pharmaceutical formulation designed for the intranasal delivery of insulin to patients. The formulation consists of an aqueous mixture of human insulin, a solubilizing agent, a surface-active agent, and a thickening agent. This innovative formulation provides an ultra-rapid acting profile for regular human insulin, which could revolutionize the way insulin is administered.

Career Highlights

Throughout her career, Annemarie has worked with various companies, including Marina Biotech, Inc. and Moderna, Inc. Her experience in these organizations has allowed her to develop her expertise in pharmaceutical formulations and drug delivery systems.

Collaborations

Annemarie has collaborated with notable professionals in her field, including Henry R. Costantino and Anthony P. Sileno. These collaborations have contributed to her success and the advancement of her innovative ideas.

Conclusion

Annemarie Stoudt Cohen is a pioneering inventor whose work in intranasal insulin delivery showcases her commitment to improving patient care. Her contributions to pharmaceutical formulations are noteworthy and have the potential to make a significant impact in the medical field.